G713-0620 Screening compound: 5-{2-[(3-{[1,4'-bipiperidin]-1'-yl}propyl)carbamoyl]ethyl}-N-phenyl-1,3,4-thiadiazole-2-carboxamide

G713-0620 Screening compound: 5-{2-[(3-{[1,4'-bipiperidin]-1'-yl}propyl)carbamoyl]ethyl}-N-phenyl-1,3,4-thiadiazole-2-carboxamide
G713-0620 Screening compound: 5-{2-[(3-{[1,4'-bipiperidin]-1'-yl}propyl)carbamoyl]ethyl}-N-phenyl-1,3,4-thiadiazole-2-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G713-0620
5-{2-[(3-{[1,4'-bipiperidin]-1'-yl}propyl)carbamoyl]ethyl}-N-phenyl-1,3,4-thiadiazole-2-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G713-0620

Molecular Formula

C25H36N6O2S (C25 H36 N6 O2 S)

Compound Name

5-{2-[(3-{[1,4'-bipiperidin]-1'-yl}propyl)carbamoyl]ethyl}-N-phenyl-1,3,4-thiadiazole-2-carboxamide

IUPAC name

5-{2-[(3-{[14'-bipiperidin]-1'-yl}propyl)carbamoyl]ethyl}-N-phenyl-134-thiadiazole-2-carboxamide

SMILES

O=C(CCc1nnc(C(Nc2ccccc2)=O)s1)NCCCN(CC1)CCC1N1CCCCC1

InChI

InChI=1S/C25H36N6O2S/c32-22(10-11-23-28-29-25(34-23)24(33)27-20-8-3-1-4-9-20)26-14-7-15-30-18-12-21(13-19-30)31-16-5-2-6-17-31/h1,3-4,8-9,21H,2,5-7,10-19H2,(H,26,32)(H,27,33)

InChI Key

ANOBRNFLMYMNPU-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15029669

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

484.67

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.978

Distribution Coefficient, logD

-0.285

Water Solubility, LogSw

-2.42

Polar Surface Area

78.446

Acid Dissociation Constant (pKa)

11.40

Base Dissociation Constant (pKb)

9.66

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

60.00

G713-0620 in Drug Discovery

Included in Screening Libraries

Anti-Inflammatory Library (24602 compounds)

Eccentric PPI Library (11937 compounds)

GPCR Targeted Library (31838 compounds)

Protein-Protein Interaction Library (218420 compounds)

Targeted Diversity Library (40567 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Mechanism of action:
  • PPI modulators
  • Receptor's ligands
  • PPI modulators
Structure:
  • Cyclic compounds
Targets:
  • GPCR

References: we are preparing a list of scientific research reports with G713-0620 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G713-0620?
Check Price and Availability of G713-0620, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G713-0620 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G713-0620
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G713-0620
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G713-0620 available by request